The blood culture from a patient of febrile neutropenia has grown Pseudomonas aeruginosa, It was found to be a producer of extended-spectrum beta-lactamase enzyme. The best choice of antimicrobial therapy should be –
## **Core Concept**
Febrile neutropenia is a medical emergency characterized by fever and neutropenia, often occurring in patients undergoing chemotherapy. Pseudomonas aeruginosa is a notorious pathogen in such patients, known for its resistance to multiple antibiotics. Extended-spectrum beta-lactamase (ESBL) production is a mechanism of resistance to beta-lactam antibiotics.
## **Why the Correct Answer is Right**
The correct answer, **C. Piperacillin/Tazobactam**, is a combination of a beta-lactam antibiotic (piperacillin) and a beta-lactamase inhibitor (tazobactam). Tazobactam inhibits ESBL enzymes, thereby protecting piperacillin from degradation. This combination is effective against ESBL-producing Gram-negative bacteria, including Pseudomonas aeruginosa, although Pseudomonas may require higher concentrations of tazobactam or additional synergistic agents. Piperacillin/tazobactam is often considered a first-line treatment for febrile neutropenia due to its broad-spectrum activity.
## **Why Each Wrong Option is Incorrect**
- **Option A: Ciprofloxacin** is a fluoroquinolone antibiotic with broad-spectrum activity but is not the best choice for Pseudomonas infections in febrile neutropenia, especially when ESBL production is a concern. Resistance rates can be high, and it does not offer the same level of synergistic effect as piperacillin/tazobactam.
- **Option B: Ceftriaxone** is a third-generation cephalosporin with good activity against many Gram-negative bacteria but lacks reliable activity against ESBL-producing organisms and Pseudomonas aeruginosa. It would not be effective in this scenario.
- **Option D: Amikacin** is an aminoglycoside antibiotic effective against many Gram-negative bacteria, including Pseudomonas. However, when used alone, it may not provide adequate coverage for severe infections, and nephrotoxicity and ototoxicity are concerns. It might be used in combination with another agent for synergistic effect but is not the best choice as monotherapy.
## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **piperacillin/tazobactam is a commonly recommended empiric therapy for febrile neutropenia** due to its broad-spectrum activity, including against Pseudomonas and ESBL-producing organisms. However, local resistance patterns and patient-specific factors should guide antibiotic selection.
## **Correct Answer:** C. Piperacillin/Tazobactam